IV 

118TH CONGRESS 

1ST SESSION H. RES. 355 

Supporting the designation of May 2023 as ‘‘National Brain Tumor 

Awareness Month’’. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 2, 2023 

Mr. QUIGLEY (for himself, Mr. MCCAUL, Mr. FITZPATRICK, Ms. CROCKETT, 

and Mr. BACON) submitted the following resolution; which was referred 

to the Committee on Energy and Commerce 

RESOLUTION 

Supporting the designation of May 2023 as ‘‘National Brain 

Tumor Awareness Month’’. 

Whereas more than an estimated 94,390 individuals will be 

diagnosed with a primary brain tumor in the United 

States in 2023, and an estimated 93,470 individuals in 

the United States were diagnosed with a primary brain 

tumor in 2022; 

Whereas an estimated 1,000,000 individuals are living with 

a brain tumor in the United States; 

Whereas, in the United States, brain tumors are the— 

(1) leading cause of death from cancer in children 

who are under 14 years of age and teens who are under 

19 years of age; and 


pbinns on DSKJLVW7X2PROD with $$_JOB
2 

•HRES 355 IH 

(2) second leading cause of death from cancer in 

young adults who are between 15 and 39 years of age; 

Whereas the average 5-year survival rate for an individual in 

the United States following the diagnosis of a primary 

malignant brain tumor is only 35.7 percent; 

Whereas it is estimated that 18,990 individuals in the United 

States will die as a result of a malignant brain tumor in 

2023; 

Whereas brain tumors may be malignant or benign but can 

be life-threatening in either case; 

Whereas treatment of brain tumors is complicated by the fact 

that more than 100 types of brain tumors exist; 

Whereas the treatment and removal of brain tumors present 

significant challenges due to the uniquely complex and 

fragile nature of the brain; 

Whereas brain tumors affect the primary organ in the human 

body that controls not only cognitive ability, but the actions of every other organ and limb in the body, leading 

to brain tumors being described as a disease that affects 

the whole individual; 

Whereas brain tumor research is supported by a number of 

private, nonprofit research foundations and by Federal 

medical research institutions; 

Whereas basic research may fuel advancements and development of new treatments for brain tumors; 

Whereas obstacles to the development of new treatments for 

brain tumors remain, and there are limited strategies for 

the screening or early detection of brain tumors; 

Whereas, despite the high number of individuals diagnosed 

with a brain tumor every year and the devastating progVerDate Sep 11 2014 22:07 May 02, 2023 Jkt 039200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6300 E:\BILLS\HR355.IH HR355

pbinns on DSKJLVW7X2PROD with $$_JOB
3 

•HRES 355 IH 

noses for those individuals, only 5 drugs and 1 medical 

device are approved by the Food and Drug Administration to treat primary brain tumors; 

Whereas the mortality rates associated with brain tumors 

have changed little during the 30-year period preceding 

the date of introduction of this resolution; 

Whereas there is a need for greater public awareness of brain 

tumors, including the difficulties associated with research 

on brain tumors and the opportunities for advances in 

brain tumor research and treatment; and 

Whereas May 2023, during which brain tumor advocates nationwide unite in awareness, outreach, and advocacy activities, is an appropriate month to recognize as ‘‘National Brain Tumor Awareness Month’’: Now, therefore, 

be it 

1 Resolved, That the House of Representatives— 

2 (1) supports the designation of ‘‘National Brain 

3 Tumor Awareness Month’’; 

4 (2) encourages increased public awareness of 

5 brain tumors to honor the individuals who have lost 

6 their lives to a brain tumor or currently live with a 

7 brain tumor diagnosis; 

8 (3) supports efforts to develop better treat9 ments for brain tumors that will improve the quality 

10 of life and the long-term prognoses of individuals di11 agnosed with a brain tumor; 


pbinns on DSKJLVW7X2PROD with $$_JOB
4 

•HRES 355 IH 

1 (4) expresses its support for individuals who are 

2 battling brain tumors, as well as the families, 

3 friends, and caregivers of those individuals; and 

4 (5) urges a collaborative approach to brain 

5 tumor research, which is a promising means of ad6 vancing understanding of, and treatment for, brain 

7 tumors. 

Æ 


pbinns on DSKJLVW7X2PROD with $$_JOB